[96a5a0]: / output / allTrials / identified / NCT05445973_identified.json

Download this file

300 lines (300 with data), 13.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
{
"info": {
"nct_id": "NCT05445973",
"official_title": "Real-Time Contrast-Enhanced Ultrasonography-CT/MRI Fusion Guidance for Percutaneous Radiofrequency Ablation of Inconspicuous, Small Liver Tumors",
"inclusion_criteria": "* inconspicuous or invisible index tumors for ablation on US\n* tumor size ≤ 3 cm\n* pathologic diagnosis of primary or secondary liver malignancy or imaging-based diagnosis of HCC according to the American Association for the Study of Liver Disease guidelines or viable HCC according to the Liver Imaging Reporting and Data System treatment response algorithm\n* consideration of curative-intent RFA\nHealthy volunteers allowed",
"exclusion_criteria": "* well-visible tumors (visibility score of 3 or 4) on the planning B-mode US\n* the absence of available data from multiphase CT or MRI performed in the 3-month pre-procedure period\n* poor quality registration of US-CT/MRI fusion imaging and RFA planned with palliative intent\n* contraindications for the conventional RFA procedure at the authors' institution, which are uncontrollable coagulopathy (platelet count < 50,000/μL or international standard ratio ≥ 1.6), a low level of cooperation, impracticality of sedation, portal vein thrombus, the tumor abutting the portal vein, or larger bile ducts than the segmental branches",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* inconspicuous or invisible index tumors for ablation on US",
"criterions": [
{
"exact_snippets": "inconspicuous or invisible index tumors",
"criterion": "index tumors",
"requirements": [
{
"requirement_type": "visibility",
"expected_value": [
"inconspicuous",
"invisible"
]
}
]
},
{
"exact_snippets": "ablation on US",
"criterion": "ablation",
"requirements": [
{
"requirement_type": "method",
"expected_value": "US"
}
]
}
]
},
{
"line": "* tumor size ≤ 3 cm",
"criterions": [
{
"exact_snippets": "tumor size ≤ 3 cm",
"criterion": "tumor size",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "cm"
}
}
]
}
]
},
{
"line": "* pathologic diagnosis of primary or secondary liver malignancy or imaging-based diagnosis of HCC according to the American Association for the Study of Liver Disease guidelines or viable HCC according to the Liver Imaging Reporting and Data System treatment response algorithm",
"criterions": [
{
"exact_snippets": "pathologic diagnosis of primary or secondary liver malignancy",
"criterion": "liver malignancy",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": "pathologic"
}
]
},
{
"exact_snippets": "imaging-based diagnosis of HCC according to the American Association for the Study of Liver Disease guidelines",
"criterion": "HCC",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": "imaging-based"
}
]
},
{
"exact_snippets": "viable HCC according to the Liver Imaging Reporting and Data System treatment response algorithm",
"criterion": "viable HCC",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": "Liver Imaging Reporting and Data System treatment response algorithm"
}
]
}
]
},
{
"line": "* consideration of curative-intent RFA",
"criterions": [
{
"exact_snippets": "consideration of curative-intent RFA",
"criterion": "curative-intent RFA",
"requirements": [
{
"requirement_type": "consideration",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* well-visible tumors (visibility score of 3 or 4) on the planning B-mode US",
"criterions": [
{
"exact_snippets": "well-visible tumors (visibility score of 3 or 4)",
"criterion": "tumor visibility",
"requirements": [
{
"requirement_type": "visibility score",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3,
"unit": "N/A"
},
{
"operator": "<=",
"value": 4,
"unit": "N/A"
}
]
}
}
]
},
{
"exact_snippets": "on the planning B-mode US",
"criterion": "imaging modality",
"requirements": [
{
"requirement_type": "type",
"expected_value": "planning B-mode US"
}
]
}
]
},
{
"line": "* the absence of available data from multiphase CT or MRI performed in the 3-month pre-procedure period",
"criterions": [
{
"exact_snippets": "absence of available data from multiphase CT or MRI",
"criterion": "multiphase CT or MRI data",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
},
{
"exact_snippets": "performed in the 3-month pre-procedure period",
"criterion": "timeframe of multiphase CT or MRI",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": "3-month pre-procedure period"
}
]
}
]
},
{
"line": "* poor quality registration of US-CT/MRI fusion imaging and RFA planned with palliative intent",
"criterions": [
{
"exact_snippets": "poor quality registration of US-CT/MRI fusion imaging",
"criterion": "US-CT/MRI fusion imaging registration quality",
"requirements": [
{
"requirement_type": "quality",
"expected_value": "poor"
}
]
},
{
"exact_snippets": "RFA planned with palliative intent",
"criterion": "RFA intent",
"requirements": [
{
"requirement_type": "intent",
"expected_value": "palliative"
}
]
}
]
},
{
"line": "* contraindications for the conventional RFA procedure at the authors' institution, which are uncontrollable coagulopathy (platelet count < 50,000/μL or international standard ratio ≥ 1.6), a low level of cooperation, impracticality of sedation, portal vein thrombus, the tumor abutting the portal vein, or larger bile ducts than the segmental branches",
"criterions": [
{
"exact_snippets": "uncontrollable coagulopathy (platelet count < 50,000/μL",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 50000,
"unit": "/μL"
}
}
]
},
{
"exact_snippets": "uncontrollable coagulopathy ... international standard ratio ≥ 1.6",
"criterion": "international standard ratio",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1.6,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "low level of cooperation",
"criterion": "level of cooperation",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "low"
}
]
},
{
"exact_snippets": "impracticality of sedation",
"criterion": "sedation",
"requirements": [
{
"requirement_type": "practicality",
"expected_value": false
}
]
},
{
"exact_snippets": "portal vein thrombus",
"criterion": "portal vein thrombus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "tumor abutting the portal vein",
"criterion": "tumor abutting the portal vein",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "larger bile ducts than the segmental branches",
"criterion": "bile ducts size",
"requirements": [
{
"requirement_type": "comparison",
"expected_value": "larger than segmental branches"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}